Revenue: The sum of all revenue fields included for a company's operating activities.
ACADIA Pharmaceuticals Inc. (ACAD) had Revenue of $307.96M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
$307.96M |
$31.50M |
|
$28.32M |
|
$279.64M |
|
$270.12M |
|
$37.84M |
|
$8.64M |
|
$46.47M |
|
$46.47M |
|
$31.50M |
|
$31.50M |
|
$31.50M |
|
$31.50M |
|
$37.84M |
|
$40.94M |
|
171.60M |
|
172.85M |
|
$0.18 |
|
$0.18 |
|
| Balance Sheet Financials | |
$1.22B |
|
$17.11M |
|
$518.36M |
|
$1.74B |
|
$361.44M |
|
-- |
|
$74.86M |
|
$436.29M |
|
$1.31B |
|
$1.20B |
|
$1.31B |
|
172.13M |
|
| Cash Flow Statement Financials | |
$134.76M |
|
$57.75M |
|
$14.72M |
|
$185.54M |
|
$392.83M |
|
$207.29M |
|
$31.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.39 |
|
-- |
|
-- |
|
-- |
|
-- |
|
90.81% |
|
12.29% |
|
12.29% |
|
-- |
|
15.09% |
|
10.23% |
|
$124.46M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.87 |
|
1.85 |
|
48.61 |
|
2.41% |
|
2.62% |
|
1.81% |
|
2.41% |
|
$7.59 |
|
$0.72 |
|
$0.78 |
|